Uterine Cervical Cancer Screening in Kitakyushu City: Present and Future

DOI Web Site Web Site PubMed 16 References
  • MATSUURA Yusuke
    Department of Nursing of Human Broad Development, University of Occupational and Environmental Health, Japan Department of Uterine Cervical Cancer Screening Surveillance, Kitakyushu Medical Association, Japan
  • OKA Haruko
    Department of Uterine Cervical Cancer Screening Surveillance, Kitakyushu Medical Association, Japan
  • YAMAGATA Kazuhiro
    Department of Uterine Cervical Cancer Screening Surveillance, Kitakyushu Medical Association, Japan
  • KIKUCHI Joji
    Department of Uterine Cervical Cancer Screening Surveillance, Kitakyushu Medical Association, Japan
  • INOUE Isao
    Department of Uterine Cervical Cancer Screening Surveillance, Kitakyushu Medical Association, Japan
  • OHKUBO Nobuyuki
    Department of Uterine Cervical Cancer Screening Surveillance, Kitakyushu Medical Association, Japan
  • TOKI Naoyuki
    Department of Obstetrics and Gynecology, Kyushu Rosai Hospital, Japan
  • KAWAGOE Toshinori
    Department of Obstetrics and Gynecology, School of Medicine, University of Occupational and Environmental Health, Japan
  • HACHISUGA Toru
    Department of Obstetrics and Gynecology, School of Medicine, University of Occupational and Environmental Health, Japan
  • KASHIMURA Masamichi
    Department of Uterine Cervical Cancer Screening Surveillance, Kitakyushu Medical Association, Japan

Bibliographic Information

Other Title
  • 北九州市における子宮頸がん検診の現状と今後の展望
  • キタキュウシュウシ ニ オケル シキュウケイ ガン ケンシン ノ ゲンジョウ ト コンゴ ノ テンボウ

Search this article

Abstract

Uterine cervical cancer is the most common primary gynecologic malignant tumor in Japan. Conventional cervical screening Papanicolaou (Pap) test has been shown to be extremely effective in reducing cervical cancer incidence and mortality, but the consultation rate for cancer screening in Japan is markedly low, at 20% of prescribed subjects, in comparison with other developed countries. In 2001, 15,501 women (6.8%) received a Pap test in Kitakyushu City, and that was less than half of national average. From 2009, free coupons for uterine cervical cancer screening were distributed to Japanese woman who were 20, 25, 30, 35 or 40 years of age as part of the project for women-specific cancer screening. The rate of participation in Pap testing was 22.3% in 2012, with 31,970 women receiving cervical tests. It was almost as high as the national level. Itʼs obvious that high risk human papillomavirus (HPV) is responsible for cervical cancer incidence and HPV mainly infects through sexual practice. The rate of early cervical neoplasms and invasive cancers is currently increasing in young women. Abnormal Pap tests were detected in 2.3% of the women in 2008. To increase the population’s participation in this screening process, a cost-effective and efficient system should be established. National and local governments, medical institutions, companies, and educational institutions must have an accurate understanding of the current situation, and take an assertive approach in order to decrease the mortality rate of uterine cervical cancer.

Journal

  • Journal of UOEH

    Journal of UOEH 36 (3), 205-215, 2014-09-01

    The University of Occupational and Environmental Health, Japan

References(16)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top